NCT00001531View on ClinicalTrials.gov

Potential Role of CMV in Restenosis Following Angioplasty, in Atherosclerosis, and in Endothelial Dysfunction

CompletedOBSERVATIONAL

Enrollment

355

Participants

Timeline

Start Date

June 30, 1996

Study Completion Date

September 30, 2000

Conditions

Arterial Occlusive DiseasesAtherosclerosisCoronary DiseaseCytomegalovirus Infections

Trial Locations (1)

20892

National Heart, Lung and Blood Institute (NHLBI), Bethesda

All Listed Sponsors

lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00001531 - Potential Role of CMV in Restenosis Following Angioplasty, in Atherosclerosis, and in Endothelial Dysfunction | Biotech Hunter | Biotech Hunter